Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Sales | 113 | 107 | 0 |
| Cost of Goods | 126 | 67 | N/A |
| Gross Profit | -13 | 40 | N/A |
| Operating Expenses | 1,101 | 3,087 | 0 |
| Operating Income | -987 | -2,980 | N/A |
| Interest Expense | 236 | 315 | 0 |
| Other Income | -1,760 | -391 | 0 |
| Pre-tax Income | -2,983 | -3,686 | 0 |
| Net Income Continuous | -2,983 | -3,686 | N/A |
| Net Income Discontinuous | -371 | -841 | N/A |
| Net Income | $-3,354 | $-4,526 | $N/A |
| EPS Basic Total Ops | -7,595.76 | -16,661.67 | N/A |
| EPS Basic Continuous Ops | -6,636.86 | -10,194.88 | N/A |
| EPS Basic Discontinuous Ops | -826.14 | -2,325.35 | N/A |
| EPS Diluted Total Ops | -7,595.76 | -16,661.67 | N/A |
| EPS Diluted Continuous Ops | -6,636.86 | -10,194.88 | N/A |
| EPS Diluted Discontinuous Ops | -826.14 | -2,325.35 | N/A |
| EBITDA(a) | $-748 | $-2,552 | $N/A |